Abstract
Introduction
Myocardial compensation in response to pressure overload involves a complex process of ventricular remodelling. Although cardiac hypertrophy is usually deemed an adaptive process to compensate the initial stress, sustained hypertrophic changes are maladaptive, resulting in certain devastating cardiac pathologies including congestive heart failure, stroke and sudden death [1, 2] . Cellular changes of cardiac hypertrophy are characterized by increased cardiomyocyte volume, expression of foetal gene and protein synthesis associated with the activation of a variety of cell signalling cascades [1] [2] [3] . In particular, calcineurin-nuclear factor of activated T-cells [4] , phosphoinositide 3-kinase (PI-3K)/Akt/glycogen synthase kinase 3 (GSK-3) [5, 6] , myocyte enhancer factor-2/histone deacetylases [7, 8] , G protein-coupled receptors [9] and mitogenactivated protein kinase [10] are among the major signalling molecules governing cardiac hypertrophic response. [11] . [12] . However, the precise role of IGF-1 in the regulation of cardiac function and geometry under both physiological and pathological conditions is still debatable. Therefore this study was designed to determine the role of IGF-1 deficiency in a murine model of pressure overloadinduced cardiac hypertrophy. Given that cardiac hypertrophy has been reported to be governed by microRNA-1, -133a and -208 [13, 14] , levels of these miRs were examined in hypertrophic hearts induced by abdominal aortic constriction (AAC) . MiRs are a group of non-coding, small RNAs to negatively control the posttranscriptional gene expression [15] . Approximately one third of the mammalian genomes are regulated by miRs with a high tissue specificity [16] . For example, miR-1, miR-133a, miR-206 and miR-208 appear to be muscle specific, whereas miR-1 and miR-133a are unique regulators for cardiac hypertrophy [17, 18] . In 
Insulin-like growth factor (IGF)-1 is an important growth factor for survival, proliferation and differentiation in the heart

McMullen and colleagues reported that IGF-1 receptor mediates physiological cardiac growth in a PI-3K-dependent manner. This finding challenges the classical viewpoint of IGF-1 being a potential candidate for the treatment of heart failure
an effort to elucidate the cellular machineries behind IGF-1 deficiency and pressure overload-induced myocardial alterations, if any, special attempt was made towards the post-IGF-1 receptor signalling molecule Akt, its downstream targets mammalian target of rapamycin (mTOR) and GSK-3␤, as well as protein phosphatase (reciprocally correlated with Akt phosphorylation)
, all of which are pivotal in the maintenance of cardiac structure and function [19] [20] [21] . Given that Akt may phosphorylate Akt substrate of 160KD (AS160) to initiate glucose transport by glucose transporter-4 (GLUT-4) [22] , phosphorylation of AS160 and GLUT-4 expression were also monitored in myocardium following pressure overload. [25] . Four weeks following operation, mice were used for experimentation. [26] .
Materials and methods
Experimental animals and AAC
Echocardiographic evaluation
Cardiomyocyte isolation and mechanics
Mouse cardiomyocytes were isolated using Liberase as described [27] . [27] . [28] . 
Histopathological analysis
Neonatal rat cardiomyocytes (NRCMs) culture and transfection
Results
General features and echocardiographic properties
The LID mice weighed significantly less than the age-matched C57 mice, as reported [33] . (Fig. 4) (Fig. 6) . [34] . In our study, the expression of miR-208 was not affected by either AAC or IGF-1 deficiency (Fig. 7) . to be decreased [37] or elevated [38] in hypertrophic cardiomyocytes. Moreover, prolonged intracellular Ca 2ϩ transients were reported in models of advanced cardiac hypertrophy [39, 40] [11, 20] . Severely dysfunctional myocardium following myocardial infarction is capable of undergoing hypertrophy associated with improved contractile function with IGF-1 treatment, favouring a beneficial effect of the growth factor [19] . To the contrary, elevated circulating IGF-1 levels are seen in acromegalic patients with cardiac hypertrophy [43] . This is consistent with the pro-hypertrophic response of IGF-1 in cardiac gene expression, the effect of which may be attenuated by IGF binding protein-3 [44] . Thus a contemporary mechanism seems to be present for IGF -1-induced [20] .
Expression of miR-1, miR-133a and miR-208 in mouse hearts
To demonstrate whether miRs were involved in the IGF-1 deficiencyblunted pressure overload-induced cardiac hypertrophy, the levels of miR-1, miR-133a and miR-208 which are all specific expressed in muscles were detected. After AAC, miR-1 and miR-133a levels were markedly decreased in C57 mice, the effect of which was nullified by IGF-1 deficiency. MiR-208 was also reported to play a role in cardiac hypertrophy
Effect of miRNA-1 and miRNA-133a on IGF-1-induced hypertrophy in NRCMs
To determine the causal-effect relationship between IGF-1 deficiencyinduced response in cardiac hypertrophy and miR expression, © 2011 The Authors Journal of Cellular and Molecular Medicine © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig. 1 Cardiomyocyte contractile properties in cells from sham-or AAC-treated C57 and LID mouse hearts. (A) Representative cell shortening traces from C57 mice with sham or AAC treatment. (B) Representative cell shortening traces from LID mice with sham or AAC treatment. (C) Resting cell length. (D) PS (normalized to cell length). (E) Maximal velocity of shortening (ϩdL/dt). (F) Maximal velocity of relengthening (-dL/dt). (G) TPS and (H) TR90. Mean Ϯ S.E.M., n ϭ 94-103 cells per group, *P Ͻ
(A) Representative gel blots depicting pan and phosphorylated Akt, GSK-3␤ and mTOR (␣-tubulin as loading control) using specific antibodies; (B) pAkt-to-Akt ratio; (C) pGSK-3␤-to-GSK-3␤ ratio and (D) pmTOR-to-
MiRs are complementary with specific mRNAs to down-regulate post-transcriptional gene expression through suppressing translation or promoting mRNA degradation [15] . MiRs are transcribed as long primary transcripts (pri-miRs) before undergoing sequential steps to mature. First, the nuclear processing of the primiRs into stem-loop precursors of ~70 nucleotides (pre-miRs), and the cytoplasmic processing of pre-miRs into mature miRs [45] . MiRs are deemed key factors for cardiac development and proliferation. In particular, miR-1 and miR-133a are considered to be muscle specific [46] . For example, MiR-1 inhibits myocyte proliferation and cardiac development [47] . The pressure overloadinduced cardiac hypertrophy displays cardiac pathology with a global change in the gene expression profile via some unknown mechanism(s). It was reported that the muscle-specific miR molecule miR-1 was down-regulated in the heart at the onset of pressure overload [48] 
